Institutional investors purchased a net $437.0 thousand shares of CCXI during the quarter ended December 2015. This may signal that the smart money is gaining interest in this company as the 57.52% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BVF PARTNERS LP Bought 552.2 Thousand shares of ChemoCentryx Inc
SIMPLEX TRADING LLC Sold 212.00 shares of ChemoCentryx Inc
CREATIVE PLANNING, INC. Sold 2.0 Thousand shares of ChemoCentryx Inc